Last quarter (Q ), Alseres Pharmaceuticals's total revenue was $18.43K, a decrease of 0.00% from the same quarter last year. In Q, Alseres Pharmaceuticals's net income was $-321.00K. See Alseres Pharmaceuticals’s key income statements, including revenue, expenses, profit, and income.

Income Statement	TTM	Dec 13	Dec 12	Dec 11	Dec 10	Dec 09
Total Revenue	$ 473.73K	$ 473.73K	$ 530.72K	$ 0.00	$ 0.00	$ 0.00
Cost of Revenue	-	$ 0.00	$ 0.00	$ 0.00	$ 0.00	$ 0.00
Gross Profit	$ 473.73K	$ 473.73K	$ 530.72K	$ 0.00	$ 0.00	$ 0.00
Operating Expense	$ 1.29M	$ 1.42M	$ 1.72M	$ 2.13M	$ 3.12M	$ 8.33M
Operating Income	$ -818.25K	$ -946.06K	$ -1.19M	$ -2.13M	$ -3.12M	$ -8.33M
Net Non Operating Interest Income Expense	$ -237.79K	$ -454.66K	$ -434.55K	$ -1.84M	$ -2.64M	$ -2.52M
Other Income Expense	$ 279.41K	$ 459.19K	$ -25.29K	$ 1.08M	$ 6.28M	$ 72.14K
Pretax Income	$ -776.64K	$ -941.53K	$ -1.65M	$ -2.88M	-	-
Tax Provision	-	-	-	-	-	-
Earnings From Equity Interest Net Of Tax	-	-	-	-	-	-
Net Income Common Stockholders	$ -776.64K	$ -941.53K	$ -1.65M	$ -2.88M	$ 512.42K	$ -10.78M
Basic EPS	$ -100.00	$ -150.00	$ -300.00	$ -500.00	$ 50.00	$ -2.30K
Diluted EPS	$ -100.00	$ -150.00	$ -300.00	$ -500.00	$ 0.00	$ -2.30K
Basic Average Shares	$ 24.51K	$ 6.13K	$ 6.13K	$ 5.92K	$ 5.34K	$ 4.67K
Diluted Average Shares	$ 24.51K	$ 6.13K	$ 6.13K	$ 5.92K	$ 6.32K	$ 4.67K
Dividend Per Share	-	-	-	-	-	-
Total Operating Income As Reported	-	-	-	-	-	-
Reported Normalized Basic E P S	-	-	-	-	-	-
Reported Normalized Diluted E P S	-	-	-	-	-	-
Rent Expense Supplemental	-	-	-	-	-	-
Total Expenses	$ 1.29M	$ 1.42M	$ 1.72M	$ 2.13M	$ 3.12M	$ 8.33M
Net Income From Continuing And Discontinued Operation	$ -776.64K	$ -941.53K	$ -1.65M	$ -2.88M	$ 512.42K	$ -10.78M
Normalized Income	$ -1.06M	$ -1.40M	$ -1.62M	$ -3.96M	$ -5.76M	$ -10.85M
Interest Expense	$ 5.24K	$ 454.66K	$ 434.55K	$ 1.84M	$ 2.64M	$ 2.52M
EBIT	$ -360.90K	$ -486.87K	$ -1.21M	$ -1.04M	$ -3.12M	$ -8.33M
EBITDA	$ -360.90K	$ -485.68K	$ -1.21M	$ -1.00M	$ -3.06M	$ -8.25M

Currency in USD

Alseres Pharmaceuticals Earnings and Revenue History

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing